EMEA-002875-PIP02-24 - paediatric investigation plan
allogeneic skin-derived ABCB5-positive dermal mesenchymal stromal cells
PIPHuman
Key facts
- Invented name
- Amesanar
- Active Substance
- allogeneic skin-derived ABCB5-positive dermal mesenchymal stromal cells
- Therapeutic area
- Skin and subcutaneous tissue disorders
- Decision number
- P/0237/2024
- PIP number
- EMEA-002875-PIP02-24
- Pharmaceutical form(s)
- All pharmaceutical forms
- Condition(s) / indication(s)
- Treatment of venous leg ulcer
- Route(s) of administration
- All routes of administration
- Contact for public enquiries
Rheacell GmbH & Co. KG
Tel: +49 6221718330
Email: office@rheacell.com- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date